AUNA

Auna

6.36 USD
+0.00
0.00%
At close Jul 11, 4:00 PM EDT
1 day
0.00%
5 days
0.63%
1 month
1.92%
3 months
-5.78%
6 months
-12.64%
Year to date
-8.88%
1 year
-19.80%
5 years
-33.75%
10 years
-33.75%
 

About: Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru and Healthcare services in Peru, Columbia and Mexico. Key revenue is generated from Peru.

Employees: 14,842

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

8% more capital invested

Capital invested by funds: $29.4M [Q4 2024] → $31.6M (+$2.21M) [Q1 2025]

0.53% more ownership

Funds ownership: 14.26% [Q4 2024] → 14.8% (+0.53%) [Q1 2025]

5% less funds holding

Funds holding: 19 [Q4 2024] → 18 (-1) [Q1 2025]

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

Research analyst outlook

We haven’t received any recent analyst ratings for AUNA.

Financial journalist opinion

Neutral
Business Wire
1 week ago
Auna Provides an Update From Its Controlling Shareholder Enfoca Regarding Its Sponsor-Level Financing
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today that its controlling shareholder, Enfoca Sociedad Administradora de Fondos de Inversión S.A. (“Enfoca”), has notified the Company about the status of its sponsor-level financing. According to Enfoca, its “sponsor-level financing which had a final maturity of October 5, 2025, has been successfully refinanced. The new faci.
Auna Provides an Update From Its Controlling Shareholder Enfoca Regarding Its Sponsor-Level Financing
Positive
Seeking Alpha
2 weeks ago
Auna: Scalable, Profitable, Misunderstood
AUNA's integrated LatAm healthcare platform is undervalued due to short-term execution, not structural flaws. The payor-provider model drives superior margins, cost efficiencies, and creates a powerful ecosystem with strong operating leverage, especially in underutilized Mexican assets. Management is actively addressing physician onboarding and payor mix, with insurance-led strategies poised to drive patient volume and profitability recovery.
Auna: Scalable, Profitable, Misunderstood
Positive
Zacks Investment Research
1 month ago
Auna S.A. (AUNA) Q1 Earnings Top Estimates
Auna S.A. (AUNA) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.10 per share a year ago.
Auna S.A. (AUNA) Q1 Earnings Top Estimates
Neutral
Business Wire
1 month ago
Auna Announces 1Q25 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 (“first quarter 2025” or “1Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 1Q25 Consolidated Highlights Consolidate.
Auna Announces 1Q25 Financial Results
Neutral
Zacks Investment Research
1 month ago
Auna S.A. (AUNA) Reports Next Week: What You Should Expect
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Auna S.A. (AUNA) Reports Next Week: What You Should Expect
Neutral
Business Wire
2 months ago
Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the “Additional Notes”) in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”.
Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029
Neutral
Business Wire
2 months ago
Auna Announces Proposed Offering of Additional 10.000% Senior Secured Notes Due 2029
MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it intends to offer additional 10.000% senior secured notes (the “Additional Notes”) in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in accordance with Re.
Auna Announces Proposed Offering of Additional 10.000% Senior Secured Notes Due 2029
Neutral
Business Wire
3 months ago
Auna Announces the Filing of Its Form 20-F for the Fiscal Year 2024
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, with the Securities and Exchange Commission (the “SEC”) on April 10, 2025. Auna's Annual Report on Form 20-F can be accessed by visiting either the SEC's website at www.sec.gov or the “Financial Info” section of the Company's Invest.
Auna Announces the Filing of Its Form 20-F for the Fiscal Year 2024
Positive
Seeking Alpha
3 months ago
Auna: Strong Q4, Execution In Mexico Will Be Key, Reiterating Buy
Auna achieved strong 2024 results with 11% revenue growth and 20% EBITDA growth, driven by successful operations in Peru and expansion efforts in Mexico. Mexico's market potential is significant, with strategic partnerships and a focus on oncologic plans, while Colombia faces regulatory challenges impacting profitability. The company is focused on deleveraging, aiming for a leverage ratio below 3X by 2025, driven by a projected 20% EBITDA growth.
Auna: Strong Q4, Execution In Mexico Will Be Key, Reiterating Buy
Negative
Zacks Investment Research
3 months ago
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Charts implemented using Lightweight Charts™